J&J Names Tom Cavanaugh to Lead Innovative Medicine

Company: Johnson & Johnson · Event Type: Leadership Transition · Role: Executive Vice President and Worldwide Chairman, Innovative Medicine · Incoming: Tom Cavanaugh · Outgoing: Jennifer Taubert (retirement) · Effective Date: September 1, 2026 Summary Johnson & Johnson announced that Jennifer Taubert will retire as…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Tags
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *

Saturday Rounds

MeiraGTx – $400M Oberland Strategic Financing for Late-Stage Gene Therapy Programs
Beeline Therapeutics – $300M Launch
Repligen Buys BioLife for $1.5 Billion
Nurix + Roche; Global BTK Degrader Collaboration